Shopping Cart
- Remove All
- Your shopping cart is currently empty
MK-0941 is an orally active and allosteric glucokinase activator, has potential in the treatment of type 2 diabetes.
Description | MK-0941 is an orally active and allosteric glucokinase activator, has potential in the treatment of type 2 diabetes. |
Targets&IC50 | GK (human recombinant):240 nM (EC50), GK (human recombinant):65 nM (EC50) |
Molecular Weight | 556.61 |
Formula | C22H28N4O9S2 |
Cas No. | 1137916-97-2 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 260 mg/mL (467.11 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.